{"data":[{"accessionNo":"0001274173-26-000210","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001759425","issuerName":"MIRUM PHARAMACEUTICALS, INC.","ticker":"MIRM","cusip":"604749101","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"JANUS HENDERSON GROUP Ltd.","reportingCik":null,"personType":"HC","sharesOwned":5909184,"percentOfClass":9.7,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0000315066-26-002080","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS INC","ticker":"MIRM","cusip":"604749101","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":3777851.04,"percentOfClass":6.2,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0000315066-26-002080","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS INC","ticker":"MIRM","cusip":"604749101","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":3777851.04,"percentOfClass":6.2,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0002012383-26-001752","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals, Inc","ticker":"MIRM","cusip":"604749101","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":3465559,"percentOfClass":5.7,"filedAt":"2026-04-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0000102909-26-001893","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals Inc","ticker":"MIRM","cusip":"604749101","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001274173-26-000084","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARAMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":6065308,"percentOfClass":11.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001580642-26-001063","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Finny Kuruvilla, M.D. Ph. D.","reportingCik":null,"personType":"HC,IN","sharesOwned":2093582,"percentOfClass":4.1,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001580642-26-001063","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Eventide Asset Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":2093582,"percentOfClass":4.1,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001580642-26-001063","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Robin C. John","reportingCik":null,"personType":"HC,IN","sharesOwned":2093582,"percentOfClass":4.1,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"Patrick J. Heron","reportingCik":"0001365617","personType":"IN","sharesOwned":4108404,"percentOfClass":6.8,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"James N. Topper","reportingCik":"0001341382","personType":"IN","sharesOwned":4025922,"percentOfClass":6.7,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"Frazier Life Sciences IX, L.P.","reportingCik":"0001720320","personType":"PN","sharesOwned":3566912,"percentOfClass":5.9,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"FHMLS IX, L.P.","reportingCik":"0001782789","personType":"PN","sharesOwned":3566912,"percentOfClass":5.9,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"FHMLS IX, L.L.C.","reportingCik":"0001782791","personType":"OO","sharesOwned":3566912,"percentOfClass":5.9,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"FHMLSP, L.P.","reportingCik":"0001879466","personType":"PN","sharesOwned":2514947,"percentOfClass":4.2,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"Frazier Life Sciences Public Fund, L.P.","reportingCik":"0001863769","personType":"PN","sharesOwned":2514947,"percentOfClass":4.2,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"FHMLSP, L.L.C.","reportingCik":"0001879465","personType":"OO","sharesOwned":2514947,"percentOfClass":4.2,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"FHMLS XI, L.P.","reportingCik":"0001911580","personType":"PN","sharesOwned":1075884,"percentOfClass":1.8,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"Frazier Life Sciences XI, L.P.","reportingCik":"0001911592","personType":"PN","sharesOwned":1075884,"percentOfClass":1.8,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"FHMLS XI, L.L.C.","reportingCik":"0001911623","personType":"OO","sharesOwned":1075884,"percentOfClass":1.8,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"FHMLS X, L.L.C.","reportingCik":"0001790811","personType":"OO","sharesOwned":459010,"percentOfClass":0.8,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"FHMLS X, L.P.","reportingCik":"0001790880","personType":"PN","sharesOwned":459010,"percentOfClass":0.8,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"Frazier Life Sciences X, L.P.","reportingCik":"0001790879","personType":"PN","sharesOwned":459010,"percentOfClass":0.8,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"FHMLS XII, L.L.C.","reportingCik":"0002052177","personType":"OO","sharesOwned":62931,"percentOfClass":0.1,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"Frazier Life Sciences XII, L.P.","reportingCik":"0002052255","personType":"PN","sharesOwned":62931,"percentOfClass":0.1,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-26-000093","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-01-23","reportingPerson":"FHMLS XII, L.P.","reportingCik":"0002052246","personType":"PN","sharesOwned":62931,"percentOfClass":0.1,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001274173-25-000321","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARAMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock","eventDate":"2025-11-28","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":5445039,"percentOfClass":10.6,"filedAt":"2025-12-05","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001274173-25-000293","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001759425","issuerName":"MIRUM PHARAMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":4997586,"percentOfClass":10,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0000921895-25-003107","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":1495290,"percentOfClass":3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0000921895-25-003107","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":1495290,"percentOfClass":3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0000921895-25-003107","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":1495290,"percentOfClass":3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0000921895-25-003107","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":1383261,"percentOfClass":2.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0000921895-25-003107","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":772595,"percentOfClass":1.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0000921895-25-003107","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":772595,"percentOfClass":1.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0000921895-25-003107","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":610666,"percentOfClass":1.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0000921895-25-003107","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":610666,"percentOfClass":1.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0000921895-25-003107","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":82238,"percentOfClass":0.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0000921895-25-003107","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001759425","issuerName":"Mirum Pharmaceuticals, Inc.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":82238,"percentOfClass":0.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-25-000420","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-01","reportingPerson":"Patrick J. Heron","reportingCik":"0001365617","personType":"IN","sharesOwned":3735220,"percentOfClass":7.6,"filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-25-000420","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-01","reportingPerson":"James N. Topper","reportingCik":"0001341382","personType":"IN","sharesOwned":3735220,"percentOfClass":7.4,"filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-25-000420","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-01","reportingPerson":"FHMLS IX, L.L.C.","reportingCik":"0001782791","personType":"OO","sharesOwned":3566912,"percentOfClass":7.1,"filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-25-000420","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-01","reportingPerson":"Frazier Life Sciences IX, L.P.","reportingCik":"0001720320","personType":"PN","sharesOwned":3566912,"percentOfClass":7.1,"filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-25-000420","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-01","reportingPerson":"FHMLS IX, L.P.","reportingCik":"0001782789","personType":"PN","sharesOwned":3566912,"percentOfClass":7.1,"filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-25-000420","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-01","reportingPerson":"Frazier Life Sciences Public Fund, L.P.","reportingCik":"0001863769","personType":"PN","sharesOwned":2514947,"percentOfClass":5,"filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-25-000420","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-01","reportingPerson":"FHMLSP, L.P.","reportingCik":"0001879466","personType":"PN","sharesOwned":2514947,"percentOfClass":5,"filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-25-000420","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-01","reportingPerson":"FHMLSP, L.L.C.","reportingCik":"0001879465","personType":"OO","sharesOwned":2514947,"percentOfClass":5,"filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-25-000420","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-01","reportingPerson":"FHMLS XI, L.L.C.","reportingCik":"0001911623","personType":"OO","sharesOwned":544954,"percentOfClass":1.1,"filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-25-000420","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-01","reportingPerson":"Frazier Life Sciences XI, L.P.","reportingCik":"0001911592","personType":"PN","sharesOwned":544954,"percentOfClass":1.1,"filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-25-000420","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-01","reportingPerson":"FHMLS XI, L.P.","reportingCik":"0001911580","personType":"PN","sharesOwned":544954,"percentOfClass":1.1,"filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-25-000420","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-01","reportingPerson":"Frazier Life Sciences X, L.P.","reportingCik":"0001790879","personType":"PN","sharesOwned":168308,"percentOfClass":0.3,"filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-25-000420","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-01","reportingPerson":"FHMLS X, L.P.","reportingCik":"0001790880","personType":"PN","sharesOwned":168308,"percentOfClass":0.3,"filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"},{"accessionNo":"0001231919-25-000420","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001759425","issuerName":"MIRUM PHARMACEUTICALS, INC.","ticker":"MIRM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-01","reportingPerson":"FHMLS X, L.L.C.","reportingCik":"0001790811","personType":"OO","sharesOwned":168308,"percentOfClass":0.3,"filedAt":"2025-11-04","canonicalUrl":"https://xoomar.com/markets/stocks/mirm"}],"updatedAt":"2026-11-05T11:38:53.790Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/mirm","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}